JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB32106

Anti-ELK1 antibody [E277]

  • RabMAb
  • Recombinant
  • KO Validated
  • Advanced Validation
  • What is this?

Be the first to review this product! Submit a review

|

(57 Publications)

Rabbit Recombinant Monoclonal ELK1 antibody. Suitable for ChIC/CUT&RUN-seq, IHC-P, WB, ICC/IF, Flow Cyt (Intra) and reacts with Human samples. Cited in 57 publications.

View Alternative Names

ETS domain-containing protein Elk-1, ELK1

8 Images
Immunocytochemistry/ Immunofluorescence - Anti-ELK1 antibody [E277] (AB32106)
  • ICC/IF

Lab

Immunocytochemistry/ Immunofluorescence - Anti-ELK1 antibody [E277] (AB32106)

Immunocytochemistry/ Immunofluorescence analysis of A549 (human lung carcinoma epithelial cell) cells labeling ELK1 with purified ab32106 at 1/500 dilution (3.8 μg/mL). Cells were fixed in 4% Paraformaldehyde and permeabilized with 0.1% tritonX-100. Goat anti rabbit IgG (Alexa Fluor® 488, ab150077) was used as the secondary antibody at 1/1000 (2 μg/mL) dilution. DAPI (blue) was used as nuclear counterstain.

Flow Cytometry (Intracellular) - Anti-ELK1 antibody [E277] (AB32106)
  • Flow Cyt (Intra)

Unknown

Flow Cytometry (Intracellular) - Anti-ELK1 antibody [E277] (AB32106)

Intracellular Flow Cytometry analysis of HeLa (human cervix adenocarcinoma) cells labeling ELK1 with unpurified ab32106 at 1/20 dilution (10ug/mL) (red). Cells were fixed with 4% paraformaldehyde and permeabilised with 90% methanol. A Goat anti rabbit IgG (Alexa Fluorr® 488) at 1/2000 dilution was used as the secondary antibody. Rabbit monoclonal IgG (Black) was used as the isotype control, cells without incubation with primary antibody and secondary antibody (Blue) were used as the unlabeled control.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-ELK1 antibody [E277] (AB32106)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-ELK1 antibody [E277] (AB32106)

Immunohistochemical analysis of paraffin embedded human breast carcinoma using ab32106 at a dilution of 1/50

Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.

Western blot - Anti-ELK1 antibody [E277] (AB32106)
  • WB

Lab

Western blot - Anti-ELK1 antibody [E277] (AB32106)

Lane 1 : Wild-type HAP1 whole cell lysate (20 μg)
Lane 2 : ELK1 knockout HAP1 whole cell lysate (20 μg)
Lane 3 : HeLa positive whole cell lysate (21 μg)
Lane 4 : MCF7 negative whole cell lysate (20 μg)

Lanes 1 - 4 : Merged signal (red and green). Green - ab32106 observed at 55 kDa. Red - loading control, ab18058, observed at 130 kDa.

ab32106 was shown to specifically react with ELK1 in wild-type HAP1 cells as signal was lost in ELK1 knockout cells. Wild-type and ELK1 knockout samples were subjected to SDS-PAGE. ab32106 and ab18058 (Mouse anti-Vinculin loading control) were incubated overnight at 4°C at 1/500 dilution and 1/20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed ab216773 and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed ab216776 secondary antibodies at 1/10000 dilution for 1 hour at room temperature before imaging.

All lanes:

Western blot - Anti-ELK1 antibody [E277] (ab32106)

Predicted band size: 45 kDa

false

Western blot - Anti-ELK1 antibody [E277] (AB32106)
  • WB

Lab

Western blot - Anti-ELK1 antibody [E277] (AB32106)

Lanes 1- 2 : Merged signal (red and green). Green - ab32106 observed at 55 kDa. Red - Anti-GAPDH antibody [6C5] - Loading Control (ab8245) observed at 37 kDa.

ab32106 was shown to react with ELK1 in wild-type HeLa cells in western blot. Loss of signal was observed when knockout cell line ab261764 (knockout cell lysate ab256904) was used. Wild-type HeLa and ELK1 knockout HeLa cell lysates were subjected to SDS-PAGE. Membrane was blocked for 1 hour at room temperature in 0.1% TBST with 3% non-fat dried milk. ab32106 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) overnight at 4°C at a 1 in 500 dilution and a 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye®800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye®680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.

All lanes:

Western blot - Anti-ELK1 antibody [E277] (ab32106) at 1/500 dilution

Lane 1:

Wild-type HeLa cell lysate at 20 µg

Lane 2:

ELK1 knockout HeLa cell lysate at 20 µg

Lane 2:

Western blot - Human ELK1 knockout HeLa cell line (<a href='/en-us/products/cell-lines/human-elk1-knockout-hela-cell-line-ab261764'>ab261764</a>)

Predicted band size: 45 kDa

Observed band size: 55 kDa

false

ChIC/CUT&RUN sequencing - Anti-ELK1 antibody [E277] (AB32106)
  • ChIC/CUT&RUN-seq

Supplier Data

ChIC/CUT&RUN sequencing - Anti-ELK1 antibody [E277] (AB32106)

CUT&RUN profiling with ELK1 antibody demonstrates robust genome-wide enrichment in cells. Heatmaps of genome-wide signal flanking annotated transcription start sites (TSSs, +/- 2 kbp) display CUT&RUN data generated using the CUTANA™ CUT&RUN Kit (EpiCypher 14-1048) with ELK1 antibody (Abcam ab32106, 0.5 µg). 500,000 HeLa cells were used per reaction. IgG antibody was included as a negative control to assess non-specific background. Libraries were prepared using the CUTANA™ CUT&RUN Library Prep Kit (EpiCypher 14-1001). Sequencing was performed with paired-end 50 bp reads, and data were processed on CUTANA™ Cloud (cloud.epicypher.com) by alignment to the hg38 genome. Heatmaps were generated using ChAsE (Younesy et al., Bioinformatics 2016; PMID 27378294). Row-linked data are ranked by intensity relative to ELK1, with red indicating high localized enrichment and blue denoting background.

ChIC/CUT&RUN sequencing - Anti-ELK1 antibody [E277] (AB32106)
  • ChIC/CUT&RUN-seq

Supplier Data

ChIC/CUT&RUN sequencing - Anti-ELK1 antibody [E277] (AB32106)

CUT&RUN profiling with ELK1 antibody reveals the expected genomic enrichment pattern in cells. Representative genome browser tracks show CUT&RUN data generated using the CUTANA™ CUT&RUN Kit (EpiCypher 14-1048) with ELK1 antibody (Abcam ab32106, 0.5 µg). 500,000 HeLa cells were used per reaction. IgG, H3K4me3, and H3K27me3 antibodies were included as controls to assess non-specific background, active promoters, and repressed chromatin, respectively. Libraries were prepared using the CUTANA™ CUT&RUN Library Prep Kit (EpiCypher 14-1001). Sequencing was performed with paired-end 50 bp reads, and data were processed on CUTANA™ Cloud (cloud.epicypher.com) by alignment to the hg38 genome. Images were generated using Integrative Genomics Viewer (IGV, Broad Institute).

Western blot - Anti-ELK1 antibody [E277] (AB32106)
  • WB

Unknown

Western blot - Anti-ELK1 antibody [E277] (AB32106)

All lanes:

Western blot - Anti-ELK1 antibody [E277] (ab32106) at 1/500 dilution

Predicted band size: 45 kDa

Observed band size: 62 kDa

false

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

E277

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

WB, IHC-P, Flow Cyt (Intra), ICC/IF, ChIC/CUT&RUN-seq

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Epitope

ab32106 reacts with an epitope located in the C terminal region of ELK1.

Specificity

This antibody does not cross react with other ETS family members

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "ChICCUTRUNseq" : {"fullname" : "ChIC/CUT&RUN sequencing", "shortname":"ChIC/CUT&RUN-seq"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"}, "FlowCytIntra" : {"fullname" : "Flow Cytometry (Intracellular)", "shortname":"Flow Cyt (Intra)"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "ChICCUTRUNseq-species-checked": "testedAndGuaranteed", "ChICCUTRUNseq-species-dilution-info": "", "ChICCUTRUNseq-species-notes": "<p></p>", "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/50", "IHCP-species-notes": "<p></p> Perform heat-mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/500", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1/500", "ICCIF-species-notes": "<p></p>", "FlowCytIntra-species-checked": "testedAndGuaranteed", "FlowCytIntra-species-dilution-info": "1/20", "FlowCytIntra-species-notes": "<p><a href='/en-us/products/primary-antibodies/rabbit-igg-monoclonal-epr25a-isotype-control-ab172730'>ab172730</a> - Rabbit monoclonal IgG, is suitable for use as an isotype control with this antibody.</p>" }, "Mouse": { "ChICCUTRUNseq-species-checked": "predicted", "ChICCUTRUNseq-species-dilution-info": "", "ChICCUTRUNseq-species-notes": "", "IHCP-species-checked": "predicted", "IHCP-species-dilution-info": "", "IHCP-species-notes": "", "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "", "ICCIF-species-checked": "predicted", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "", "FlowCytIntra-species-checked": "predicted", "FlowCytIntra-species-dilution-info": "", "FlowCytIntra-species-notes": "" }, "Rat": { "ChICCUTRUNseq-species-checked": "predicted", "ChICCUTRUNseq-species-dilution-info": "", "ChICCUTRUNseq-species-notes": "", "IHCP-species-checked": "predicted", "IHCP-species-dilution-info": "", "IHCP-species-notes": "", "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "", "ICCIF-species-checked": "predicted", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "", "FlowCytIntra-species-checked": "predicted", "FlowCytIntra-species-dilution-info": "", "FlowCytIntra-species-notes": "" } } }

Product details

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 50% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

ELK1 also known as ELK-1 or ETS-domain protein ELK1 is a transcription factor involved in regulating gene expression. It is a member of the ETS family of transcription factors and has a molecular mass of approximately 54 kDa. ELK1 is mainly expressed in the nucleus of cells and plays a significant role in various tissues by interacting with other proteins. It has sequence-specific DNA-binding ability which allows it to influence the transcription of target genes.
Biological function summary

ELK1 functions in the regulation of gene expression related to cellular proliferation and differentiation. It often forms a ternary complex with serum response factor (SRF) on serum response elements (SREs) to modulate the transcriptional responses of genes important for cell growth. The activation of ELK1 is phosphorylation-dependent primarily by mitogen-activated protein kinases (MAPKs) which further facilitates its role as a transcription regulator. This phosphorylation increases the transcriptional activity enabling ELK1 to actively participate in cellular responses to external signals.

Pathways

ELK1 participates prominently in the MAPK/ERK signaling pathway and the JNK signaling pathway. Through these pathways ELK1 gets activated influencing the transcription of immediate early genes responsible for cell cycle progression and apoptosis. ELK1 interacts with other proteins in these pathways such as MEK and ERK leading to a coordinated response to growth signals. These interactions underline its importance in signal transduction processes and cellular response mechanisms.

ELK1 has associations with certain cancers and neurodegenerative disorders. In particular its dysregulation has been noted in the context of breast cancer where ELK1 is implicated in abnormal cell proliferation. Similarly in neurodegenerative diseases like Alzheimer's ELK1's altered activity levels can affect neuron function and survival. Other proteins such as amyloid precursor protein in Alzheimer's or estrogen receptor in breast cancer connect with ELK1 influencing disease progression through complex signaling networks.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Transcription factor that binds to purine-rich DNA sequences (PubMed : 10799319, PubMed : 7889942). Forms a ternary complex with SRF and the ETS and SRF motifs of the serum response element (SRE) on the promoter region of immediate early genes such as FOS and IER2 (PubMed : 1630903). Induces target gene transcription upon JNK and MAPK-signaling pathways stimulation (PubMed : 7889942).
See full target information ELK1

Publications (57)

Recent publications for all applications. Explore the full list and refine your search

Clinical epigenetics 17:146 PubMed40886022

2025

Selective disruption of DNMT1/ELK1 interactions induces DGKI re-expression and promotes temozolomide sensitivity of MGMT/DGKI glioblastoma.

Applications

Unspecified application

Species

Unspecified reactive species

Jean-Maxime Besson,Amandine Etcheverry,Arulraj Nadaradjane,Gwenola Bougras-Cartron,Marc Aubry,Jean-Sebastien Frenel,Alain Chevanieu,Marie Lopez,Jean Mosser,Pierre-François Cartron

Experimental & molecular medicine 57:1032-1046 PubMed40307574

2025

ELK1 inhibition alleviates amyloid pathology and memory decline by promoting the SYVN1-mediated ubiquitination and degradation of PS1 in Alzheimer's disease.

Applications

Unspecified application

Species

Unspecified reactive species

Lilin Yi,Junjie Li,Yan He,Jiaojiao Wang,Maoju Wang,Song Guo,Man Luo,Bin Wu,Mingliang Xu,Qiuyun Tian,Yepeng Fan,Mulan Chen,Boqing Xu,Lei Xia,Weihong Song,Guiqiong He,Yehong Du,Zhifang Dong

Annals of medicine 56:2424515 PubMed39529543

2024

Hsa_circRNA_000166 accelerates breast cancer progression via the regulation of the miR-326/ELK1 and miR-330-5p/ELK1 axes.

Applications

Unspecified application

Species

Unspecified reactive species

Ming-Hui Wang,Zi-Hui Liu,Hong-Xu Zhang,Han-Cheng Liu,Li-Hui Ma

Annals of medicine and surgery (2012) 86:5767-5775 PubMed39359848

2024

Elevated expression of ELK1 promotes breast cancer cell growth and correlates with poor prognosis of breast cancer patients.

Applications

Unspecified application

Species

Unspecified reactive species

Xiuping Xu,Yanan Wang,Qing Wang,Shanmei Lv,Guofeng Mao

Cell proliferation 57:e13635 PubMed38594962

2024

The antioxidant effect of tetrahedral framework nucleic acid-based delivery of small activating RNA targeting DJ-1 on retinal oxidative stress injury.

Applications

Unspecified application

Species

Unspecified reactive species

Qiaowei Wu,Jingyi Zhu,Xianggui Zhang,Xiaoxiao Xu,Delun Luo,Yunfeng Lin,Ming Yan,Yanping Song

International journal of molecular sciences 25: PubMed38397056

2024

ELK1/MTOR/S6K1 Pathway Contributes to Acquired Resistance to Gefitinib in Non-Small Cell Lung Cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Lei Zhao,Yifang Wang,Xin Sun,Xiujuan Zhang,Nicole Simone,Jun He

iScience 26:107143 PubMed37456852

2023

Selective activation of PPARα maintains thermogenic capacity of beige adipocytes.

Applications

Unspecified application

Species

Unspecified reactive species

Gentaro Egusa,Haruya Ohno,Gaku Nagano,Junji Sagawa,Hiroko Shinjo,Yutaro Yamamoto,Natsumi Himeno,Yoshimi Morita,Akinori Kanai,Ryuta Baba,Kazuhiro Kobuke,Kenji Oki,Masayasu Yoneda,Noboru Hattori

Journal of traditional and complementary medicine 13:600-610 PubMed38020551

2023

Xiaozheng pill exerts an anti-mammary hyperplasia effect through Raf/ERK/ELK and HIF-1α/bFGF pathways.

Applications

Unspecified application

Species

Unspecified reactive species

Yu-Fei Liu,Tian An,Hong Yu,Ying-Yi Fan,Xiao-Hua Pei

Protein expression and purification 203:106216 PubMed36528218

2022

Comparative analysis of protein expression systems and PTM landscape in the study of transcription factor ELK-1.

Applications

Unspecified application

Species

Unspecified reactive species

Charles Ducker,Manohar Ratnam,Peter E Shaw,Robert Layfield

Cell cycle (Georgetown, Tex.) 22:117-130 PubMed35941836

2022

ELK1-Induced upregulation of long non-coding TNK2-AS1 promotes the progression of acute myeloid leukemia by EZH2-mediated epigenetic silencing of CELF2.

Applications

Unspecified application

Species

Unspecified reactive species

Dongfang Guo,Airong Zhang,Meifang Suo,Ping Wang,Yile Liang
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com